Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Leede Jones Gable initiates coverage - $12.50 Target
View:
Post by Youhillman on Mar 25, 2021 11:57pm

Leede Jones Gable initiates coverage - $12.50 Target

Just came across this on a tweet, thought I'd share the information....this means the company now has coverage by three companies with many more to come next month with a NASDAQ listing.

 

Leede Jones Gable has initiated coverage on Canadian biotechnology firm Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) with a ‘Speculative Buy’ rating.

In a note Thursday, the research firm cited Oakville, Ontario-based Cardiol’s revenue potential from its ultrapure cannabidiol formulation Cortalex, which was launched last year through the Medical Cannabis by Shoppers portal.

Leede Jones Gable analyst Douglas Loe wrote that the alliance should generate top-line growth while clinical trials – including the Phase II/III trial of its flagship product CardiolRx – continue in the background.

“Cannabidiol’s clinical prospects in cardiovascular disease are, perhaps surprisingly at least to us initially, quite well-documented in the medical literature in preclinical models of disease,” Loe wrote, “and our diligence thus suggests to us that Cardiol’s initiative to more fully test cannabidiol’s clinical prospects is justified and with strong prospects for value creation based on future Phase II/III efficacy signals that we expect to transpire during our forecast period.

“What we found most striking in our investigation of cannabidiol’s medical prospects in cardiovascular disease was just how well-characterized its prospects actually were in this disease category, despite which few if any firms other than Cardiol are exploring this activity,” he added.

The analyst cited a number of diseases that could potentially be treated with Cortalex, including coronavirus-associated cardiovascular disease, acute myocarditis and diastolic heart failure.

Loe also noted that Cardiol’s strategic manufacturing alliance for CardiolRx with Purisys and Dalton Pharma Services provides competitive advantages in medical markets where cannabidiol purity is critical to clinical success.

Comment by Youhillman on Apr 08, 2021 11:52am
I just received the full analyst report by LGJ, thought I'd share it by copying the link to it. As I stated previously we need a catalyst to move the SP off the low $4.00 range. The NASDAQ listing should be completed sometime this quarter, I'm hoping by month end. Phase One AM results by the FDA were delayed due to Covid issues getting priority but they have been completed and ...more  
Comment by Mapleleaf57 on Apr 08, 2021 5:21pm
you guys are saying the same thing over and over again,,, by months end,, by months end,,, bunch of donkeys,,, I think CRDL should fire your *sses,,,how do you all sleep at night pushing a dead end stock
Comment by SlangEditor00 on Apr 08, 2021 7:08pm
HAHA we are the same thing over and over again. You said all this cr*p at $2.50 as well. Elsley must of hooked up with your old lady.
Comment by Mapleleaf57 on Apr 08, 2021 9:03pm
yup you got it,,, thats something a 13 year old would say,,,
Comment by SlangEditor00 on Apr 14, 2021 9:01pm
Sounds like the same garbage you were slinging a few months ago. Being bitter will get you nowhere. Givemeabreak and go mapledink youself.
Comment by Mapleleaf57 on Apr 15, 2021 8:54pm
yup you said it Slangeator,,,, your repeating the same garbage you said months months ago,,, 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities